Clinical Trials Browser

Rectal Neoplasms

Anus Neoplasms

Colorectal Neoplasms

Biliary Tract Neoplasms

Pancreatic Neoplasms

Locally Advanced Rectal Cancer

Carcinoma, Hepatocellular

Capecitabine

Rectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Adenocarcinoma

Solid Tumors

Neoplasms, Obesity

Neoplasm Metastasis, Rectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Cholangitis, Sclerosing, Klatskin Tumor

Clinical Trials

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Adaptive Radiation in Anal Cancer

Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer

PARC

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

The Therapeutic Effect of Different Doses of Capecitabine

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer

Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Alpe2U

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

DESIR

CALORIE

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

CAP7/7

mEGA

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

PC02

PC01

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer

Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.

Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy